Investment in ŠMK was completed in July, BaltCap said in a press release without disclosing the size of investment.
“We have identified private healthcare services in Lithuania as a strong and sustainable growth opportunity and believe that ŠMK, with its track-record of medical excellence, strong management and well-established corporate governance, represents an attractive consolidation platform in this market,” the press release quoted Kornelijus Celutka, investment director at BaltCap, as saying.
Rusanda Pajedienė, director of ŠMK, added that the investment by BaltCap would enable ŠMK to grow, both organically and by making acquisitions.
ŠMK operates six primary care clinics in Tauragė, Marijampolė, Lentvaris, and three residential areas of Vilnius. ŠMK has more than 17,000 registered patients and employs 100 doctors and other professionals.
BaltCap invested in the company through its Lithuania SME Fund. This fund provides growth equity financing of up to 10 million litas (EUR 2.9m) per company.
